Company Name, Ticker, Suppliers, else..

• Revenue Y/Y

• Op. Income Y/Y

• Cop. Income Y/Y

• Net Income Y/Y

• Eps Cop. Y/Y

• Eps Net Y/Y

• Free Cash Flow Y/Y

• Cash Flow Y/Y

• Sales Y/Y Annual

Valuation Comparisons

Management Effectiveness

Financial Strength

Dividend Comparisons

Renovorx Inc (RNXT)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

RNXT's Revenue Growth by Quarter and Year

Renovorx Inc 's Revenue results by quarter and year

Select the Comparisons :

None ▼

Select the Ratio:

Revenue Growth Y/Y▼

None ▼

Revenue Growth Y/Y▼

RNXT Revenue (in millions $)		FY 2022	FY 2021	FY 2020	FY 2019
IV Quarter	December	-	0.00	0.00	0.00
III Quarter	September	0.00	0.00	0.00	0.00
II Quarter	June	0.00	0.00	0.00	0.00
I Quarter	March	0.00	0.00	0.00	0.00
FY		0.00	0.00	0.00	0.00

RNXT Revenue third quarter 2022 Y/Y Growth Comment

Renovorx Inc in the third quarter 2022 recorded of $ 0.00 millions.

According to the results reported in the third quarter 2022, Renovorx Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Renovorx Inc ' s Revenue no change of % ranks overall at the positon no. in the third quarter 2022.

RNXT Revenue ( Y/Y Growth %)		2022	2021	2020	2019
IV Quarter	December	-	-	-	-
III Quarter	September	-	-	-	-
II Quarter	June	-	-	-	-
I Quarter	March	-	-	-	-
FY		-	-	-	-

Financial Statements
Renovorx Inc 's third quarter 2022 Revenue	$ 0.00 millions	RNXT's Income Statement
Renovorx Inc 's third quarter 2021 Revenue	$ 0.00 millions	Quarterly RNXT's Income Statement
New: More RNXT's historic Revenue Growth >>

RNXT Revenue (Quarter on Quarter Growth %)		2022	2021	2020	2019
IV Quarter	December	-	-	-	-
III Quarter	September	-	-	-	-
II Quarter	June	-	-	-	-
I Quarter	March	-	-	-	-
FY (Year on Year)		-	-	-	-

Explore RNXT Customer Growth by Product and Service >> Back to RNXT Growth rate Comparisons >>

Revenue third quarter 2022 Y/Y Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall	#

Revenue Y/Y Growth Statistics
High	Average	Low
0 %	0 %	0 %

Revenue third quarter 2022 Y/Y Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall	#

Revenue Y/Y Growth Statistics
High	Average	Low
0 %	0 %	0 %

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Renovorx Inc 's Q/Q Revenue Growth

Revenue Q/Q Growth Statistics
High	Average	Low
0 %	0 %	0 %

RNXT's III. Quarter Q/Q Revenue Comment

Revenue Q/Q Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall	#

Revenue Q/Q Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall	#

Revenue Q/Q Growth Statistics
High	Average	Low
0 %	0 %	0 %

RNXT's III. Quarter Q/Q Revenue Comment

Renovorx Inc 's 12 Months Revenue Growth Year on Year

Revenue TTM Growth	12 Months Ending (Sep 30 2022)	12 Months Ending (Jun 30 2022)	12 Months Ending (Mar 31 2022)	12 Months Ending (Dec 31 2021)	12 Months Ending (Sep 30 2021)
Cumulative Revenue 12 Months Ending	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Y / Y Revenue Growth (TTM)	-	-	-	-	-
Year on Year Revenue Growth Overall Ranking	#	#	#	#	#
Seqeuential Revenue Change (TTM)	-	-	-	-	-
Seq. Revenue Growth (TTM) Overall Ranking	#	#	#	#	#

New: More RNXT's historic Revenue Growth >>

Cumulative Revenue growth Comment

In the Sep 30 2022 period, Renovorx Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Renovorx Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High	Average	Low
0 %	0 %	0 %

Revenue TTM Y/Y Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall	#

Revenue TTM Y/Y Growth Statistics
High	Average	Low
0 %	0 %	0 %

Revenue TTM Q/Q Growth Company Ranking
Within:	No.
Industry	#
Sector	#
S&P 500	#

Cumulative Revenue growth Comment

In the Sep 30 2022 period, Renovorx Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Renovorx Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High	Average	Low
0 %	0 %	0 %

Revenue TTM Y/Y Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall	#

Revenue TTM Y/Y Growth Statistics
High	Average	Low
0 %	0 %	0 %

Revenue TTM Q/Q Growth Company Ranking
Within:	No.
Industry	#
Sector	#
S&P 500	#

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RNXT's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for RNXT's Competitors
Revenue Growth for Renovorx Inc 's Suppliers
Revenue Growth for RNXT's Customers

You may also want to know
RNXT's Annual Growth Rates	RNXT's Profitability Ratios	RNXT's Asset Turnover Ratio	RNXT's Dividend Growth
RNXT's Roe	RNXT's Valuation Ratios	RNXT's Financial Strength Ratios	RNXT's Dividend Payout Ratio
RNXT's Roa	RNXT's Inventory Turnover Ratio	RNXT's Growth Rates	RNXT's Dividend Comparisons

Companies with similar Revenue no change for the quarter ending Sep 30 2022 within Healthcare Sector	Y/Y Change %	Revenue for the quarter ending Sep 30 2022
Owens and Minor Inc	-0.19%	$ -0.191 millions
National Research Corporation	-0.20%	$ -0.201 millions
Livanova Plc	-0.24%	$ -0.241 millions
Healthcare Services Group Inc	-0.27%	$ -0.265 millions
Catalent Inc	-0.29%	$ -0.293 millions
Asensus Surgical Inc	-0.31%	$ -0.311 millions
Liquidia Corporation	-0.43%	$ -0.429 millions
Integra Lifesciences Holdings Corp	-0.43%	$ -0.432 millions
Pediatrix Medical Group Inc	-0.62%	$ -0.615 millions
China Pharma Holdings Inc	-0.64%	$ -0.642 millions
Acadia Pharmaceuticals Inc	-0.68%	$ -0.682 millions
Syneos Health Inc	-0.89%	$ -0.891 millions
Innovage Holding Corp	-1.07%	$ -1.070 millions
Procyon Corp	-1.20%	$ -1.200 millions
Precipio inc	-1.38%	$ -1.380 millions
Ati Physical Therapy Inc	-1.40%	$ -1.397 millions
Ocular Therapeutix Inc	-1.55%	$ -1.547 millions
Alpine Immune Sciences Inc	-1.75%	$ -1.750 millions
Surgalign Holdings Inc	-1.79%	$ -1.786 millions
Tenet Healthcare Corp	-1.90%	$ -1.900 millions
Teleflex Incorporated	-1.92%	$ -1.923 millions
Novocure Limited	-1.95%	$ -1.952 millions
Dynatronics Corporation	-2.01%	$ -2.014 millions
Royalty Pharma Plc	-2.10%	$ -2.101 millions
National Healthcare Corp	-2.13%	$ -2.130 millions
Fonar Corporation	-2.27%	$ -2.271 millions
Psychemedics Corp	-2.35%	$ -2.353 millions
Escalon Medical Corp	-2.63%	$ -2.626 millions
Lifevantage Corp	-2.72%	$ -2.724 millions
West Pharmaceutical Services Inc	-2.77%	$ -2.774 millions


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar NCRA's Profile Stock Price NCRA's Financials Business Description Fundamentals Charts & Quotes NCRA's News Suppliers NCRA's Competitors Customers & Markets Economic Indicators NCRA's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071